This later set of experiments (n = 3 in triplicate) confirmed the trend highlighted in our previous publication [4] and more importantly illustrates p53 is an important positive modulator in the UBXN2A-mot-2 pathway but that it is not an essential core component of UBXN2A's anti-cancer pathway. The gene discussed is HSPA9; the disease is cancer.